- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Clinical Laserthermia Systems AB: Updated clinical guidelines provide clear recommendations on the use of Laser Interstitial Thermal Therapy (LITT) in patients with metastatic brain tumors and radiation necrosis | 47 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (publ) ("CLS or the "Company") today announces that updated clinical guidelines with recommendations supporting the use of Laser Interstitial Thermal Therapy (LITT)... ► Artikel lesen | |
| 08.04. | Clinical Laserthermia Systems AB: Proposed U.S. tariffs expected to have minimal impact on CLS business | 71 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") clarifies that the proposed U.S. tariffs are expected to have minimal impact on its total business, including operations... ► Artikel lesen | |
| 27.02. | Clinical Laserthermia Systems AB raises up to SEK 37m through a directed issue for accelerated commercialization and expansion | 1 | Cision News | ||
| 24.02. | Clinical Laserthermia Systems steigert Umsatz trotz Verlusten | 1 | IT BOLTWISE | ||
| CLINICAL LASERTHERMIA SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 21.02. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2024 | 116 | GlobeNewswire (Europe) | Summary of the year-end report (relates to the Group)Full year (01/01/2024-12/31/2024)
Net sales totaled SEK 18,783,000 (SEK 8,273,000).
Operating profit/loss totaled SEK -54,254,000 (SEK -65,933... ► Artikel lesen | |
| 07.02. | Clinical Laserthermia Systems AB: CLS co-founder and former CEO Lars-Erik Eriksson leaves the board of directors at his own request | 1.044 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that Lars-Erik Eriksson, co-founder, long-time board member and former CEO, is leaving the board of directors... ► Artikel lesen | |
| 30.01. | Clinical Laserthermia Systems AB: Data from the clinical trial using MRI-guided FLA with TRANBERG® Thermal Therapy System in patients with prostate cancer at Radboud University Medical Center (Nijmegen, NL) is now published | 1 | Cision News | ||
| 14.01. | Clinical Laserthermia Systems AB: CLS Recaps 2024 and Provides Outlook for 2025-26 | 477 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that, in its recap of 2024, in the first nine months of 2024 compared to the same period 2023, CLS saw... ► Artikel lesen | |
| 09.12.24 | Clinical Laserthermia Systems AB: The Nomination Committee of Clinical Laserthermia Systems AB has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on June 28, 2024. | 2 | Cision News | ||
| 23.10.24 | Clinical Laserthermia Systems AB: CLS focus entirely on its successful neurosurgery business positioning the company for sustainable high-margin growth with a more streamlined operation | 178 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces it will focus entirely on its successful neurosurgery business to drive sustainable high-margin growth... ► Artikel lesen | |
| 19.07.24 | Nasdaq Stockholm AB: New equity rights for trading, Clinical Laserthermia Systems AB TO 7 B | 427 | GlobeNewswire | At the request of Clinical Laserthermia Systems AB, Clinical Laserthermia
Systems AB equity rights will be traded on First North Growth Market as from
July 22, 2024.
Security name: Clinical Laserthermia... ► Artikel lesen | |
| 11.07.24 | Nasdaq Stockholm AB: New last trading day for paid subscription units (BTU) of Clinical Laserthermia Systems AB (Record Id 269640) | 363 | GlobeNewswire | At the request of Clinical Laserthermia Systems AB, the last trading day in
Clinical Laserthermia Systems AB's paid subscription units will be changed from
2024-07-12 to 2024-07-16.
Instrument:... ► Artikel lesen | |
| 11.06.24 | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Clinical Laserthermia Systems AB (Record Id 265418) | 571 | GlobeNewswire | With effect from June 12, 2024, the unit rights in Clinical Laserthermia
Systems AB will be traded on First North Growth Market. Trading will continue
up until and including June 20, 2024.
Instrument:... ► Artikel lesen | |
| 07.06.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.06.2024 | 1.550 | Xetra Newsboard | Das Instrument FKG US12776P5070 CAPRICORN E.LS-,034265734 EQUITY wird cum Kapitalmassnahme gehandelt am 07.06.2024 und ex Kapitalmassnahme am 10.06.2024 The instrument FKG US12776P5070 CAPRICORN E.LS-... ► Artikel lesen | |
| 29.05.24 | Clinical Laserthermia Systems AB: CLS publishes interim report January - March 2024 | 231 | GlobeNewswire (Europe) | CLS publishes interim report January - March 2024Summary of the interim report (relates to the Group)Three months (01/01/2024-03/31/2024)
Net sales totaled SEK 3,140,000 (SEK 587,000).
Profit/loss... ► Artikel lesen | |
| 25.04.24 | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 25.04.2024 | 591 | Xetra Newsboard | The following instruments on XETRA do have their first trading 25.04.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 25.04.2024
Aktien
1 CA09263C1068 Blackrock Inc. CDR
2... ► Artikel lesen | |
| 24.04.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.04.2024 | 557 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 24.04.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.04.2024.ISIN NameCA56450P2008 MANTARO... ► Artikel lesen | |
| 24.04.24 | XFRA ISIN CHANGE | 589 | Xetra Newsboard | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS03815U3005 Applied DNA Sciences Inc. 24.04.2024 US03815U4094 Applied DNA Sciences Inc. 25.04.2024 Tausch 20:1CA56450P2008 First... ► Artikel lesen | |
| 24.04.24 | Nasdaq Stockholm AB: Reverse Split and Change of ISIN for Clinical Laserthermia Systems AB | 432 | GlobeNewswire | Referring to the bulletin from Clinical Laserthermia Systems AB's annual
general meeting, held on April 12, 2024, the company will carry out a reverse
stock split in relations 1:200. The share will... ► Artikel lesen | |
| 24.04.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 24.04.2024 | 1.013 | Xetra Newsboard | Das Instrument IQCY LU2023679256 LIF-SM.CIT.ETF DLA ETF wird cum Kapitalmassnahme gehandelt am 24.04.2024 und ex Kapitalmassnahme am 25.04.2024 The instrument IQCY LU2023679256 LIF-SM.CIT.ETF DLA ETF... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
Das Unternehmen CLINICAL LASERTHERMIA SYSTEMS AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,224 Euro und damit -6,47 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CLINICAL LASERTHERMIA SYSTEMS AB finden Sie auf Wallstreet Online.
